Hepatitis B virus‐induced hyperactivation of B cells in chronic hepatitis B patients via TLR4
Authors:
Open Access
- 11 May 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (11) , 6096-6106
Abstract
B cell hyperactivation and functional impairment were identified from patients with chronic hepatitis B virus (CHB) infection; however, the underlying mechanism remains unknown. Here, we aim to elucidate the mechanisms responsible for B cell hyperactivation during HBV infection. Peripheral CD19+ B cells isolated from 4 CHB patients and 4 healthy volunteers were analysed by RNA sequencing. A total of 1401 differentially expressed genes were identified from B cell transcriptome of CHB patients vs healthy volunteers. We found that B cells from CHB patients were functional impaired, with increased TLR4 expression, activated NF‐κB pathway and altered mitochondrial function. The expression of B cell activation‐related genes, including TLR4, was further validated using additional clinical samples. To further verify the role of TLR4 in B cell activation during CHB, B cell phenotypes were determined in wild‐type (WT) and TLR4−/− HBV‐carrier mice. Hyperactivated B cell and TLR4 signalling pathway were observed in WT HBV‐carrier mice, while TLR4 ablation failed to induce B cell hyperactivation, and downstream MyD88 and NF‐κB were also not altered. Taken together, TLR4 pathway plays a pivotal role in B cell hyperactivation during CHB, which might serve as a promising target for B cell function restoration.Keywords
Funding Information
- Nanjing Medical Science and Technique Development Foundation (QRX17121)
- Jiangsu Science and Technology Development Plan (BE2017605)
- Medical Science and Technology Development Foundation of Nanjing (YKK16118)
- Natural Science Foundation of Jiangsu Province for Young Scholar (BK20160121)
- National Natural Science Foundation of China (81672025, 81501749, 81600201, 81702011)
- Jiangsu Provincial Medical Innovation Team (CXTDA2017005)
- Foundation project of Jiangsu Commission of Health (Q2017003)
- Jiangsu Provincial Young Medical Talent (QNR2016007)
- Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (ZDX16004)
This publication has 33 references indexed in Scilit:
- Integration of B cell responses through Toll-like receptors and antigen receptorsNature Reviews Immunology, 2012
- Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infectionsJournal of Hepatology, 2011
- Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium InfectionImmunity, 2010
- TLR4 Promotes B Cell Maturation: Independence and Cooperation with B Lymphocyte-Activating FactorThe Journal of Immunology, 2010
- Linking oxidative stress to inflammation: Toll-like receptorsFree Radical Biology and Medicine, 2010
- Hepatitis B virus infectionThe Lancet, 2009
- Toll‐like Receptors in AutoimmunityAnnals of the New York Academy of Sciences, 2008
- Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonistsNature Medicine, 2007
- An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infectionProceedings of the National Academy of Sciences, 2006
- Toll‐like receptor stimulation as a third signal required for activation of human naive B cellsEuropean Journal of Immunology, 2006